Serum high-sensitivity C-reactive protein, tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-17A and IL-23 levels in patients with hidradenitis suppurativa

Creative Commons License

Ozturk G. S., Ergun T., Eyuboglu İ., Akkiprik M.

CYTOKINE, cilt.144, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 144
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.cyto.2021.155585
  • Dergi Adı: CYTOKINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Hidradenitis suppurativa, hs-CRP, TNF-alpha, IL-1 beta, IL-17A, IL-23
  • Marmara Üniversitesi Adresli: Evet

Özet

Background: Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease that leads to scar formation. The immune pathogenesis of HS is not fully understood and inhibitors of tumor necrosis factor (TNF)-alpha, interleukin (IL)-17, IL-1, IL-23 can be used for treating HS. Identification of serum biomarkers may help understanding individual differences in HS pathogenesis, evaluating disease severity and developing more effective treatment methods.